Poop pills take on superbugs in new clinical trial
NCT ID NCT07265817
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether taking capsules containing fecal matter from healthy donors can eliminate drug-resistant bacteria living in the gut. Sixty patients with carbapenem-resistant Enterobacteriaceae will receive either the real transplant or a placebo for three days. The goal is to see if the treatment can turn their lab tests negative for the superbug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fecal microbiota transplant capsules
- What this could lead to
- If it works, this could offer a way to remove dangerous drug-resistant bacteria from the gut without antibiotics, reducing infection risk.
- What could go wrong
- This is a small, early-stage trial with only 60 participants. The treatment may not work for everyone, and there is a small risk of infection or side effects from the transplant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARBAPENEM-RESISTANT ENTEROBACTERIACEAE COLONIZATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.